In Vivo Delivery of Gremlin siRNA Plasmid Reveals Therapeutic Potential against Diabetic Nephropathy by Recovering Bone Morphogenetic Protein-7
Qingxian Zhang, Yonghong Shi, Jun Wada et al. · 2010
Read In Vivo Delivery of Gremlin siRNA Plasmid Reveals Therapeutic Potential against Diabetic Nephropathy by Recovering Bone Morphogenetic Protein-7 by Qingxian Zhang, Yonghong Shi, Jun Wada et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011709.txt.
Description
Qingxian Zhang and co-authors tested a gene-silencing treatment for diabetic kidney disease, in PLOS ONE in 2010. Diabetic nephropathy is complex and poorly understood, and current treatments are limited. A developmental protein called gremlin, which blocks helpful bone morphogenetic proteins, had emerged as a suspect driver of the damage.
The team delivered RNA designed to silence gremlin into living animals. Silencing it restored levels of the protective protein BMP-7 and eased the kidney disease. The result in a living system marks gremlin as a promising treatment target for a condition with few options.
Catalog record
| CREATOR | Qingxian Zhang, Yonghong Shi, Jun Wada et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011709